Primary Nucleation of Polymorphic α-Synuclein Dimers Depends on Copper Concentrations and Definite Copper-Binding Site

Carmia Blacher,Karina Abramov-Harpaz,Yifat Miller
DOI: https://doi.org/10.3390/biom14060627
IF: 6.064
2024-05-27
Biomolecules
Abstract:The primary nucleation process of α-synuclein (AS) that forms toxic oligomeric species is the early stage of the pathological cause of Parkinson's disease. It is well-known that copper influences this primary nucleation process. While significant efforts have been made to solve the structures of polymorphic AS fibrils, the structures of AS oligomers and the copper-bound AS oligomers at the molecular level and the effect of copper concentrations on the primary nucleation are elusive. Here, we propose and demonstrate new molecular mechanism pathways of primary nucleation of AS that are tuned by distinct copper concentrations and by a specific copper-binding site. We present the polymorphic AS dimers bound to different copper-binding sites at the atomic resolution in high- and low-copper concentrations, using extensive molecular dynamics simulations. Our results show the complexity of the primary nucleation pathways that rely on the copper concentrations and the copper binding site. From a broader perspective, our study proposes a new strategy to control the primary nucleation of other toxic amyloid oligomers in other neurodegenerative diseases.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: the influence of copper ion concentration and specific copper - binding sites on the primary nucleation process of α - synuclein (AS) dimer polymorphism. Specifically, the study aims to reveal how different copper ion concentrations (low and high concentrations) and three specific copper - binding sites (N - terminal domain, His50 and C - terminal domain) regulate the primary nucleation process of AS dimers, and thus affect the early stage of AS aggregation in Parkinson’s disease (PD). ### Research Background Parkinson’s disease is a neurodegenerative disease. Its pathological features include Lewy bodies and Lewy neurites, which are mainly composed of oligomers and fibrils of α - synuclein (AS). Recent studies have shown that AS oligomers are more neurotoxic than fibrils and play a key role in the primary nucleation process of AS aggregation. Copper ions are considered to accelerate AS aggregation, but the specific mechanism is still unclear. In addition, the relationship between copper ion concentration and the onset of PD is also controversial. ### Research Objectives 1. **Explore the influence of copper ion concentration on the primary nucleation of AS**: Through molecular dynamics simulations, study the primary nucleation process of AS dimers under different copper ion concentrations (low and high concentrations). 2. **Analyze the role of specific copper - binding sites**: Study the specific influence of copper ions on the three main binding sites (N - terminal domain, His50 and C - terminal domain) in AS dimers on the primary nucleation. 3. **Reveal the copper ion regulation mechanism**: Provide new molecular mechanism pathways to explain how copper ions affect AS aggregation in PD by regulating the primary nucleation process of AS dimers. ### Main Findings - **Influence of copper ion concentration**: High copper ion concentration usually inhibits the β - sheet formation of the N - terminal and NAC domains, thereby inhibiting the primary nucleation; while low copper ion concentration may promote the primary nucleation of the NAC domain in some cases. - **Role of copper - binding sites**: - N - terminal domain: Copper ion binding will disrupt the β - sheets of the N - terminal and NAC domains and inhibit the primary nucleation. - His50: Copper ions can bind to His50 in AS dimers, but not in AS fibrils. - C - terminal domain: Copper ion binding will increase the flexibility of the C - terminal domain, which may affect the primary nucleation. ### Conclusion This study reveals the complex regulatory mechanism of copper ion concentration and specific copper - binding sites on the primary nucleation process of AS dimers through molecular dynamics simulations. These findings not only help to understand the molecular mechanism of AS aggregation in PD, but also provide new strategies for controlling similar aggregation processes in other neurodegenerative diseases. ### Formula Display To ensure the correctness and readability of the formulas, the following are some formulas involved in the article: - Copper ion binding energy calculation formula: \[ E_{\text{binding}} = E_{\text{complex}} - (E_{\text{protein}} + E_{\text{Cu}^{2+}}) \] where \( E_{\text{complex}} \) is the energy of the complex, \( E_{\text{protein}} \) is the energy of the protein, and \( E_{\text{Cu}^{2+}} \) is the energy of the copper ion. - Boltzmann factor calculation formula: \[ P_{i \to j} = e^{-\frac{(E_j - E_i)}{kT}} \] where \( E_i \) and \( E_j \) are the energies of conformation i and j respectively, \( k \) is the Boltzmann constant, and \( T \) is the absolute temperature. These formulas are used to evaluate the energy changes and probability distributions in copper ion binding sites and the primary nucleation process.